Cargando…
In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications
The last two decades have witnessed a tremendous growth in probiotics and in the numbers of publications on their potential health benefits. Owing to their distinguishing beneficial effects and long history of safe use, species belonging to the Lactobacillus genus are among the most widely used prob...
Autores principales: | Gangaiah, Dharanesh, Mane, Shrinivasrao P., Tawari, Nilesh R., Lakshmanan, Nallakannu, Ryan, Valerie, Volland, Alyssa, Susanti, Dwi, Patel, Milind, Abouzeid, Abraham, Helmes, Emily B., Kumar, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791467/ https://www.ncbi.nlm.nih.gov/pubmed/35081129 http://dx.doi.org/10.1371/journal.pone.0262663 |
Ejemplares similares
-
Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659
por: Sendelius, Malin, et al.
Publicado: (2023) -
Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis
por: Ojetti, Veronica, et al.
Publicado: (2022) -
Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis
por: Gupta, Nitasha, et al.
Publicado: (2020) -
Recombinant Limosilactobacillus (Lactobacillus) delivering nanobodies against Clostridium perfringens NetB and alpha toxin confers potential protection from necrotic enteritis
por: Gangaiah, Dharanesh, et al.
Publicado: (2022) -
Elucidating the molecular physiology of lantibiotic NAI-107 production in Microbispora ATCC-PTA-5024
por: Gallo, Giuseppe, et al.
Publicado: (2016)